Clinical Trial Detail

NCT ID NCT04318678
Title CD123-Directed Autologous T-Cell Therapy for Acute Myelogenous Leukemia (CATCHAML)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors St. Jude Children's Research Hospital
Indications

acute myeloid leukemia

Therapies

Cyclophosphamide + Fludarabine + MB-102 + Mesna + Rituximab

Age Groups: adult child

No variant requirements are available.